TIS tissue therapies limited

market action - , page-6

  1. 445 Posts.
    lightbulb Created with Sketch. 7
    funny - we hit a 52 week low on EU trial and results completion, FDA classification, partner in Europe, potential sales in now only 6 months. And trials about to begin in USA.

    I think I am going to buy more now. My only concern are the conditions in Europe - but up until Monday TIS had held up very well in the market sell-off since May this year.

    Short term noise re: partnering. I think and hope it will settle soon.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.